๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous T-cell Lymphoma (CTCL)

Local Registry of Primary Cutaneous T-cell Lymphomas NCT07160023n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma NCT07754890Phase 1, Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: golidocitinib, Chidamide TreAtments and outComes in paTients With prImary CutAneous Lymphoma NCT05518851n/a5 sites๐Ÿ“ Beijing๐Ÿ“ Guandong๐Ÿ“ Nanjing Peking University First Hospital Photopheresis in Early-stage Mycosis Fungoides NCT05680558Phase 21 site๐Ÿ“ New York Columbia University ยท Tests: UVADEXยฎ (methoxsalen) Sterile Solution in conjunction with the THERAKOSยฎ CELLEX Photopheresis, THERAKOSยฎ CELLEX photophโ€ฆ Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245Phase 21 site๐Ÿ“ Columbus Jonathan Brammer ยท Tests: Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure, Biospecimen Collecโ€ฆ SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites๐Ÿ“ Nijmegen๐Ÿ“ Maastricht๐Ÿ“ Amsterdam Leiden University Medical Center A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides NCT05296304Phase 13 sites๐Ÿ“ Commack๐Ÿ“ New York๐Ÿ“ Rockville Centre Memorial Sloan Kettering Cancer Center ยท Tests: Bexarotene, Total Skin Electron Beam (TSEB) Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778Phase 1, Phase 21 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Duvelisib, Venetoclax JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06716658Phase 22 sites๐Ÿ“ Tianjin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: JAK1 Inhibitor Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) NCT07047885Phase 11 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Ropeginterferon alfa-2b A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma NCT06436677n/a3 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University First Hospital ยท Tests: molecular subtype based treatment A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma NCT04045470NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Microdevices, Standard of care therapy, Standard of care systemic therapy Tissue Repository: CTCL Collection Protocol NCT02840747n/a1 site๐Ÿ“ New York Columbia University Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment NCT01087333n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas NCT07022964Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Shanghai๐Ÿ“ Shanghai Beijing GoBroad Hospital ยท Tests: CD5 CAR-T cells infusion Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Pembrolizumab, Mogamulizumab Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma NCT04234048Phase 110 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Los Angeles SciTech Development, Inc. ยท Tests: Fenretinide Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab NCT04014374n/a1 site๐Ÿ“ Milwaukee Kyowa Kirin, Inc. Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968Phase 11 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC), GM-CSF A Vaccine (VSV-hIFNฮฒ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma NCT03017820Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma NCT04128072Phase 213 sites๐Ÿ“ Copenhagen๐Ÿ“ Bordeaux๐Ÿ“ Paris European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Mogamulizumab, Total Skin Electron Beam Therapy (TSEB), Mogamulizumab (subsequent cycles post TSEB) A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Characterization of the Microbiome in Cutaneous T Cell Lymphoma NCT03932279n/a1 site๐Ÿ“ Chicago Northwestern University A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653Phase 215 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ New Haven Prescient Therapeutics, Ltd. ยท Tests: PTX-100 Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma NCT05996185Phase 22 sites๐Ÿ“ New Haven๐Ÿ“ New York Yale University ยท Tests: Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research NCT00177268n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh ยท Tests: Blood draw, skin biopsy or urine collection A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites๐Ÿ“ Duarte๐Ÿ“ San Diego๐Ÿ“ San Francisco Memorial Sloan Kettering Cancer Center ยท Tests: Optional Blood Sample and Nail Sample Combating Cancer-Related Fatigue: A Personalized Supportive Care Program NCT06860880NA1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Exercise, Diet Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma NCT03011814Phase 1, Phase 24 sites๐Ÿ“ Duarte๐Ÿ“ New York๐Ÿ“ Philadelphia City of Hope Medical Center ยท Tests: Durvalumab, Laboratory Biomarker Analysis, Lenalidomide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy